The PRAC news – October 2013
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) gave new recommendations on its October 2013 meeting about the safe use of medicines in European Union Member States.
The PRAC has concluded that the benefits of combined hormonal contraceptives continue to outweigh their risks. The PRAC confirmed the recommendation that hydrohyethyl-starch (HES) solutions must no longer be used to treat patients with sepsis or burn injuries or critically ill patients. In addition, the review of valproate-containing medicines and related substances and their use in pregnant woman has started.
Detailed information is accessible under the following link.